TGF-beta receptor fusion protein pharmaceutical composition and use thereof
US-12559539-B2 · Feb 24, 2026 · US
Jiangsu Hengrui Medicine Co holds 383 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 383 |
| Recent patents | 40 |
| First publication | Jan 1, 2015 |
| Latest publication | Feb 24, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12559539-B2 · Feb 24, 2026 · US
US-12559488-B2 · Feb 24, 2026 · US
US-2026022166-A1 · Jan 22, 2026 · US
US-2025353879-A1 · Nov 20, 2025 · US
US-12466856-B2 · Nov 11, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12559539-B2 · Feb 24, 2026 · US
US-12559488-B2 · Feb 24, 2026 · US
US-2026022166-A1 · Jan 22, 2026 · US
US-2025353879-A1 · Nov 20, 2025 · US
US-12466856-B2 · Nov 11, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 372 |
| Chemistry & Metallurgy | 331 |
| Cross-Sectional Technologies | 37 |
| Physics | 31 |
| Operations & Transport | 6 |
Answers are generated from the same data shown on this page.